Enveric Biosciences (ENVB) News Today

$0.90
+0.11 (+13.92%)
(As of 05/16/2024 ET)
Enveric Biosciences GAAP EPS of -$0.61
Enveric Biosciences Inc (ENVB)
Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?
Enveric stock jumps 13% on pipeline update
5 Biotech stocks tapping into unmet mental health treatment needs (ENVB)
Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments.
Get Enveric Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter.

[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)

Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls.

Claim your free seat by clicking here now.

ENVB Media Mentions By Week

ENVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENVB
News Sentiment

0.18

0.55

Average
Medical
News Sentiment

ENVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENVB Articles
This Week

8

1

ENVB Articles
Average Week

Get Enveric Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ENVB) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners